Letters to Officials
CCAGW Joins Coalition Opposing Superfund Tax
The Superfund tax would harm consumers and job creators in the middle of an economic recovery.
CCAGW Joins Coalition Opposing Increased Antitrust Enforcement
Increased antitrust enforcement would lead to less innovation and wasteful use of taxpayer money.
CCAGW Joins Coalition Opposing BRIDGE Act
The BRIDGE Act would increase the size and scope of government in broadband deployment, while limiting the powers of the states.
CCAGW Urges House to Oppose INVEST in America Act
The INVEST in America Act would fund wasteful programs while falling short of its intended goal.
CCAGW Joins Coalition Opposing Federal Minimum Wage Increase
CCAGW opposes efforts to raise the minimum wage
CCAGW Urges House Judiciary Committee to Oppose Antitrust Legislation
June 22, 2021 Committee Members House Judiciary Committee U.S. House of Representatives Washington, D.C. 20515 Dear Representative,
CCAGW Urges Senate to Oppose BRIDGES Act
The BRIDGE Act of 2021 creates more wasteful, unnecessary government spending.
CAGW Sends "Folly of Government-Owned Networks" to Governors
CAGW sends an issue brief on government-owned networks to governors.
CAGW Sends "The Folly of Government-Owned Networks" to Congress
May 25, 2021 U.S. Senate/U.S. House of Representatives Washington, D.C. 20510 Dear Senator/Representive,
CCAGW Joins Coalition Opposing H.R. 3
CCAGW joins coalition opposing the Lower Drug Costs Now Act, which will impose new taxes and price controls on medical innovation.
CAGW Submits Comments to APPG Inquiry
CAGW expresses its support for the U.K.’s APPG for Vaping’s report on the upcoming WHO FCTC COP9 meeting
Letter to Senate Opposing the "Hotline" of S. 1435
S. 1435 is a bill that would amend the FTC Act with regard to pharmaceutical patents and “product hopping.”
